Very High Risk Acute Lymphoblastic Leukemia
1 clinical trials · Condition
◉ Watch Very High Risk Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation (NCT06247501) | Seoul National University Hospital | 2024-01-19 |
Track Very High Risk Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.